Wednesday, February 22, 2012

News and Events - 23 Feb 2012




21.02.2012 11:00:00
The substitution of brand-name antiepileptic drugs with cheaper generic equivalents has been an ongoing point of contention among doctors, federal officials and people with epilepsy. The U.S. Food and Drug Administration claims generic antiepileptic drugs have the same dosage, purity and strength as their brand-name counterparts and the two are interchangeable...



21.02.2012 21:30:00
News and Announcements updated



22.02.2012 15:56:32
Drug maker Mylan's fourth quarter net income soars [The Pittsburgh Tribune-Review] From Pittsburgh Tribune-Review (PA (February 22, 2012 Feb. 22--Generic drug maker Mylan Inc. said it earned $129.5 million, or 30 cents a share, in the fourth...



21.02.2012 23:27:00
Drug Approval Listing



22.02.2012 0:53:18


Hindgra medication is an effective medication that serves men.
Hindgra contains sildenafil citrate , an effective compound for treating ED problems. Results with Hindgra tablets online are easy and fast. Men find it easy to consume Hindgra tablets since these tablets have almost no side effects.

The price factor associated with this medication affects the brand medication sales as this medication is very low in cost. Hindgra treats impotence problems . This medication is effective and available in bulk at many online pharmacy stores. Hindgra is a blessing for couples who were earlier unable to enjoy the fruits of life.

Hindgra is cheap and effective medication. This medication helps men to overcome problems caused due to Erectile dysfunction in men. Edegra, Penegra and Caverta are the most effective medication and popular brands of Hindgra. To treat impotence with Hindgra is an easy job. Just buy Hindgra online at – The best online store to buy Hindgra and Generic Medication online.

megalis 10 mg is what
megalis 20
megalis 20 mg safety
megalis 20 tablets used
megalis 20 viagra women
megalis 20mg
megalis online
megalis review
megalis side effect
megalis side effects
megalis20
nizagara dosage
pfiagra slidenafil




21.02.2012 23:19:00

Teva Pharmaceutical Industries will pay more than a quarter-billion dollars to settle close to 200 lawsuits stemming from Southern Nevada's hepatitis C outbreak.

The international generic drug-making giant reached an agreement late last week to settle with 41 plaintiffs represented by lawyers Robert Eglet and Will Kemp, who were in the middle of their third trial against Teva.

"It's been resolved," Kemp said.

The agreement was reached after several long days of talks under the direction of Chief District Judge Jennifer Togliatti.

Teva had previously settled about 120 cases, including those being handled by lawyers Ed Bernstein and Gerald Gillock.

The company had paid or set aside about $270 million to cover the lawsuits filed in Nevada, according to a Friday filing with the U.S. Securities and Exchange Commission.

The company will pay another $15 million this financial quarter, Teva USA spokeswoman Denise Bradley said in an email.

Permalink |
Leave a comment  »




21.02.2012 18:24:00
Generic drug maker Mylan Inc. this morning reported fourth-quarter net income rose to $129.5 million, or 30 cents per share, up from $2.6 million, or 1 cent, in the year-earlier period.

No comments:

Post a Comment